Basic Information
RINALIX TABLET 2.5 mg
TABLET, FILM COATED
Regulatory Information
SIN11664P
September 13, 2001
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XC03BA11
Company Information
APEX PHARMA MARKETING PTE. LTD.
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
INDAPAMIDE
Strength: 2.5 mg
Detailed Information
Contraindications
**Contraindications** Anuria, stroke, recent cerebrovascular accident, severe hepatic insufficiency, known hypersensitivity to indapamide or to other sulfonamide-derived drugs.
Indication Information
**Indications** Rinalix is indicated for the treatment of essential hypertension, alone or in combination with other antihypertensive drugs.